Draft Programme

08:00-17:00 REGISTRATION & REFRESHMENTS
  SASMO CONGRESS- Hall 1 A SASCETS
10:00-10:10 WELCOME & CONGRESS OPENING:
Prof G Demetriou Chairs: Prof G Demetriou & Dr Adam Nosworthy
SYMPOSIUM HOSTED BY SANOFI GENZYME: MEETING ROOM 21
10:10-11:00 FALKSON HONORARY LECTURE: Access to cancer treatment in low-middle income countries: Prof Paul Ruff  Welcome: Dr Rashem Mothilal
11:00-11:50  Changing Physician Incentives for Affordable, Quality Cancer Care: Prof Lee Schwartzberg  Chair: Dr David Brittain 
10:05-10:50  Avoidance of chemotherapy for autologous stem cell mobilisation: a realistic choice?
Prof Ben Bruno
10:50-11:20  Cost comparison mobilization – Plerixafor vs Chemo:
Dr David Brittain
11:20-11:50  Optimizing stem cell mobilization:
Dr Sharlene Parashnath 
11:50-12:20  Anti-thymocyte globulin in patients undergoing haematopoietic cell transplantation from unrelated donors:
Dr Danie Kotze
12:20-12:30  Panel Discussion:
Dr David Brittain
11:50-12:30 Neutropenia and the Judicious use of Growth Factors: Prof B Rapoport
12:30-13:30 LUNCH SYMPOSIUM HOSTED BY MSD: MEETING ROOM 21 LUNCH  SYMPOSIUM HOSTED BY NOVARTIS :
MEETING ROOM 12

ELTROMBOPAG – Speaker: DR KAREN GUNTHER; Chair: DR MICHAEL CASS
  SASMO CONGRESS SASCETS – MEETING ROOM 11CD
BREAST CANCERS – TRACK 1 Chairs: Dr D Moodley & Dr Shane Cullis
13:30-14:00 Early HER2-positive breast cancers: Escalation and De-escalation time for a  treatment revolution: Dr Devan Moodley Myeloma working party
Facilitator: Dr David Brittain 
14:00-14:30 Neoadjuvant Treatment of Her2 positive and Triple Negative Breast Cancer: Prof Lee Schwartzberg
14:30-14:40 Prognostic factors associated with pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy. The importance of Ki-67 and molecular subtype: Dr Bernardo Rapoport MSD INDUSTRY-SPONSORED SYMPOSIUM
Chair: Dr Estelle Verburgh
Anti-fungal prophylaxis post allogeneic stem cell transplant: Dr Matthew Seftel 
14:40-14:50 Neoadjuvant chemotherapy among patients treated for nonmetastatic breast cancer in a population with a high HIV prevalence: Prof Paul Ruff
14:50-15:00  Value of Genetic Testing in Breast Cancer: Ms Andrea Glick 
15:00-15:30 REFRESHMENT BREAK  SPONSORED BY ACCORD HEALTH
15:30-16:30 GYNAE MALIGNANCIES – TRACK 1 – Dr Poovan Govender & Dr Robie Dent SASCETS AGM- MEETING  ROOM 11CD
15:30-16:00  Cervical Cancer Screening, Staging and Treatment: Dr Mariza Tunmer                                                                                                                 CAR-T and gene editing therapies, a strategy for South Africa. Facilitator: Prof Michael Pepper
16:00-16:10 Clinician and Patient Reported Outcomes for Severe Late Bladder and Gastrointestinal Toxicity in Locally Advanced Cervical Cancer Patients Treated with Chemoradiation : Dr Prinitha Pillay 
16:10-16:45 Ovarian Cancer :Current surgical management: Dr Bruce Howard
16:45-17:45 SASMO AGM SASCETS AGM
Chair:Dr David Brittain 
18:00 EXHIBITION OPENING & WELCOME COCKTAIL 
07:30-17:00 REGISTRATION & REFRESHMENTS
08:00-09:00 BREAKFAST SYMPOSIUM HOSTED BY ASTRA : MEETING ROOM 21
09:00-09:05 Opening of Joint Plenary Session Chairs: Prof Bernardo Rapoprt Dr David Brittain Dr Chris Venter 
09:05-09:35 Precision Oncology: Who, How, What, When, and When Not? Prof Lee Schwartzberg 
09:35-10:05 Lessons to be Learnt: The evolution of Oncofertility in France: Prof Grynberg 
10:05-10:35 CAR-T therapy in haematologic diseases: Prof Matthew Seftel
10:35-11:00 REFRESHMENT BREAK SPONSORED BY JANSSEN
  SASMO SASOPh – PHARMACISTS SASREG SASCETS
  HALL 1A
COLORECTAL CANCER TRACK 1 Chairs: Prof P Ruff & Dr Omondi Ogude
MEETING ROOM 11B
TRACK 2
Chairs: Marlene Ellis & Marthie Hendriksz
MEETING ROOM 12B
TRACK 3 
Chairs: Dr Chris Venter 
MEETING ROOM 11CD
TRACK 4:
SASCeTS SCIENTIFIC PROGRAMME: AUTOLOGOUS TRANSPLANTATION
Chair: Dr Theo Gerdener
MEETING ROOM 11A 
TRACK 5:
ALLIED HEALTH SCIENCES PROGRAMME
Chair: Avril De Beer
11:00-11:30 Adjuvant Treatment in Colorectal Cancer: Who and For How Long? Prof Marc Peeters SASOPh: Membership and the way forward: Carien van der Merwe Cancer treatment and the damaging effects to future fertility:
Dr Stephan Volschenk 
Mobilisation and conditioning in multiple myeloma: Prof B Bruno The Clinical Pshycologist as part of the multidiciplinary team in the ACT Unit:
Dr Heather McLoughlin
11:30-12:00 Markers and next generation sequencing in colorectal cancers: Prof Simon Nayler Value of Clinical Pharmacy in Oncology:
Ina Swanepoel 
Current fertility preservation options available to female and male oncology patient:
Prof Igno Siebert
11:30-11:45: Donor quality and transplant probabilities driven through innovation and partnerships:
Alana James
11:45-12:00: Outcomes of bone marrow stem cell transplants over 44 months in a single center based on age, induction therapy and maintenance:
Dr David Brittain
12:00-12:15: Trends in haematopoietic stem cell transplantation – Experience from the South African National Blood Service:
Colwyn Poole
12:15-12:30: Autologous transplant for relapsed or refractory Hodgkin lymphoma: Outcomes in the University of Cape Town academic transplant centre between 2005 to 2017:
Estelle Verburgh
Nursing: Cancer Pain
Sr Rowan Robinson
12:00-12:30 Metastatic Colorectal cancer Treatment & Outcomes: Prof Marc Peeters Follow up on PHD study: Occupational exposure to antineoplastic drugs and the development of tailor-made risk control strategies in South African oncology pharmacies: Ruan Botha  Barriers to oncofertility care:
Establishing a National Collaboration network:
Dr Chris Venter 
Nutritional challenges before, during and after transplant: Zelda Hugo
12:30-13:30 LUNCH SYMPOSIUM HOSTED BY ROCHE  MEETING ROOM 12 – Dr Devan Moodley: LUNCH SPONSORED BY KEY ONCOLOGICS
  HALL 1A- TRACK 1:
Chairs Dr Ashraf Wadee
LUNG CANCER 
MEETING ROOM 11B
TRACK 2
Chairs: Hayley Gower and Karin Robertson
MEETING ROOM 12B
TRACK 3
MEETING ROOM 11CD
TRACK 4:
SASCeTS SCIENTIFIC PROGRAMME:
AUTOLOGOUS TRANSPLANTATION
Chair: Dr Karen Gunther
MEETING ROOM 11A
TRACK 5:
ALLIED HEALTH SCIENCES PROGRAMME
Chair: Sr Eileen Claasens
13:30-14:00 First-line treatment in irresectable non-small cell lung cancer without known EGFR mutations or ALK rearrangements:  Dr David Carbone Paediatric Oncology – Dr Monica Vaithilingum (Paediatric Haematologist)   Clinical Debate:
Complete remission is a prerequisite to autologous transplantation
For: Dr Hannes Koornhof
Against: Dr Andrew Mc Donald
A basic introduction to CAR T-cell therapy – what’s all the fuss? Dr Michael Cass
14:00-14:30 Lung Cancer Mutations Detected by Next-Generation Sequencing and/or Liquid Biopsy:  Prof Simon Nayler Proffered Paper:
CINV: Teresa Smit
  “Understanding the difference between myeloma, lymphoma and leukemia”
Andrea Brummer
14:30-15:00 Treatment in irresectable non-small cell lung cancer with known EGFR mutations or ALK rearrangements:
Dr David Carbone
Reading and understanding blood results in oncology: Rowan Robertson   ASCT in younger and older Myeloma Patients: Prof B Bruno Counselling for post-transplant role adjustments: Avril de Beer
15:00-15:30 REFRESHMENT BREAK SPONSORED BY TAKEDA
15:30-16:40 HALL 1A TRACK 1:
Chairs: Dr Johaan Raats & Dr Ria David 
PROFFERED PAPERS 
MEETING ROOM 11 B
TRACK 2
Chair: Jacomina (Miempie) Truter
MEETING ROOM 12B
TRACK 3
MEETING ROOM 11CD
TRACK 4:
SASCeTS SCIENTIFIC PROGRAMME:
AUTOLOGOUS TRANSPLANTATION
Chair: Dr Sharlene Parasnath
MEETING ROOM 11A
TRACK 5:
ALLIED HEALTH SCIENCES PROGRAMME
Chair: Dr Heather McLoughlin
  15:30-15:40 The management of side-effects of oral EGFR inhibitors – a case study:
Ms C Barker
15:40-15:50 ALK positive NSCLC remains poorly understood:
Ms L Jooste
15:50-16:00 Telephone Algorhythm:
Ms Andrea Brummer
16:00-16:10 A case report: brca2 positive, platinum sensitive ovarian cancer with breast metastases:
Ms Liezel Heyman
16:10-16:20 Sexual Quality of Life in Patients Treated for Locally Advanced Cervical Cancer with Definitive Concurrent Chemoradiation:
Dr Prinitha Pillay
16:20-16:30 Interim Analyses LANREL07484: Quality of Life in Patients with Symptomatic Gastroenteropancreatic Neuroendocrine Tumours Treated with Lanreotide Autogel in South Africa:

M Mashudu
16:30-16:40  Risk factors associated with nausea in patients receiving guideline-based anti-emetic prophylaxis. A prospective, observational, real world study:

Teresa Smit
Interactive debate:
Addressing  expectations between oncology pharmacists and oncologists:
Tegan Bilse/Johan Labuschagne/ Dr Ronwyn Van Eeden/Dr Neil Littleton
  Choosing Wisely (Ethics):
Dr Matthew Seftel
Nursing:
Anticipatory nausea and vomiting:
Sr Eileen Claasen
Nursing:

Extra corporeal photopheresis as second line treatment for Graft versus Host disease 
Sr Murial Wentzel
19:00-23:30 CONGRESS DINNER- AMGEN 
07:30-08:00 REGISTRATION & REFRESHMENTS
8:30-9:30 NOVARTIS SYMPOSIUM: MEETING ROOM 12
Advances in the treatment of BRAF-Mutant Metastatic Melanoma: Prof Axel Hauschild
MEETING ROOM 11CD
TRACK 4:
SASCeTS SCIENTIFIC PROGRAMME: ALLOGENEIC  TRANSPLANTATION

Chair: Dr David Brittain
08:00 – 08:40:What is the role of allogeneic transplantation in multiple myeloma?
Prof Benedetto Bruno
  HALL 1A – TRACK 1:
Chairs: Prof Lydia Dreosti &Dr Coenraad Slabber
ETHICS & PROFFERED PAPERS
08:40 – 09:00: Management of donor-specific antibodies in haploidentical transplantation:
Dr Justin du Toit
9:30-10:00 Chairs: Prof Lydia Dreosti
Perverse Incentives:The Slippery Slope: Elsabe Klinck
10:00-10:30 10:10-10:20: Zulu speaking patients’ responses to a cancer diagnosis, a qualitative study:
Louise Walker
10:20-10:30:  Motivations and Authorizations:
Ms Andrea Brummer
10:00-10:30: Role of autologous stem cell transplantation in Multiple Sclerosis:
Prof Richard Burt 
10:30-11:00 REFRESHMENT BREAK SPONSORED BY MSD
  HALL 1A
TRACK 1
MELANOMA
Chairs: Dr Ronwyn Van Eeden & Dr Richard Khanyile
MEETING ROOM 11CD
TRACK 4:
SASCeTS SCIENTIFIC PROGRAMME: ALLOGENIC TRANSPLANTATION
Chair: Dr Sharlene Parasnath
11:00-11:30 Adjuvant Treatment of Melanoma: Who and What?
Prof Axel Hauschild
Decentralised approach to CAR-T cell therapy:
Dr Boro Dropulic
11:30-12:10 11:30-11:40: Pneumonitis associated with nivolumab treatment in patients with different cancer types at a single centre including a case report of late onset pneumonitis :
Dr Ronwyn Van Eeden
11:40-12:10: Metastatic Maelanoma What treatment for which patient:
Prof Axel Hauschild
11:30-11:45:Design and implementation of a spreadsheet-based clinical decision support system in a busy chemotherapy clinic in a resource-limited setting: Prof.Anthony Oyekunle and Dr Tlotle Ralefala
11:45-12:00: South African Bone Marrow Registry South African Bone Marrow Registry (SABMR) Doing it Digitally in 2018 : 
Jane Ward
12:00-12:15: Comparing outcomes of matched related-, matched unrelated- and haploidentical donor allogeneic stem cell transplants performed for patients with myeloid malignancies: A 4 year review of a single centre experience:
Dr Michael Cass
12:15-12:30: Haploidentical Haematopoietic stem cell transplantation – a South African perspective from 3 different centres :
Justin Du Toit
12:10-12:30 Prize presentation and Chairperson’s Closing
12:30-12:45   SASCeTS CLOSING: DR DAVID BRITTAIN
12:45 DEPARTURES